DGX vs JPM Stock Comparison

DGX currently leads JPM in this stock comparison, with AIQ scores of 60 vs 53. The clearest difference is momentum, while JPM has the stronger risk resilience profile.

Market data as of Oct 31, 2026 market close· AIQ score gap 7 points
DGX
Healthcare
vs
JPM
Financial Services
DGX
Quest Diagnostics Incorporated
Leads
Price
$252
Day move
-0.43%
AIQ Score
60/100
Best edge
Momentum
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Price
$337
Day move
-1.9%
AIQ Score
53/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between DGX and JPM?

DGX leads the current stock comparison as Quest Diagnostics Incorporated, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Quest Diagnostics Incorporated vs JPMorgan Chase & Co.

Data as of Oct 31, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 66/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

DGX leads

DGX leads by 7 AIQ points, primarily on Momentum and Value, and the lead has widened from 1 points over 30 sessions. Wall Street currently favors JPM on target upside.

Fragile: 3 of 6 evidence groups support DGX, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
DGX

Quest Diagnostics Incorporated

Leads
AIQ Score
60/100
AIQ Edge Score
8/10
JPM

JPMorgan Chase & Co.

AIQ Score
53/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors DGX over JPM, 60 versus 53 as of Oct 31, 2026. DGX's advantage is driven primarily by stronger momentum and value, while JPM holds the stronger risk resilience profile. DGX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors JPM. 3 of 6 covered evidence groups favor DGX today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. DGX lead: Strengthening — the AIQ differential moved from 1 to 7 points over 30 sessions.

Compare Quest Diagnostics Incorporated and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

DGX
+84.5%
JPM
+126.3%

Total return comparison

Growth of $10,000, distributions reinvested

DGX $18,453 · JPM $22,633

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare DGX and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

DGX advantage
0
JPM advantage
  • Momentum83 vs 61
    DGX +22
  • Risk Resilience60 vs 69
    JPM +9
  • Value52 vs 44
    DGX +8
  • Quality48 vs 46
    Even

3 of 6 evidence groups favor DGX. DGX’s edge is concentrated in momentum and value; JPM keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.

DGX0 AIQ

No factor moved materially.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

JPM+1 AIQ

Largest factor move: Momentum +2

New signals

  • BB Upper Band Breach — bearish, volatility, short horizon

DGX's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — DGX and JPM both carry a full feed there.

The central trade-off

DGX (Quest Diagnostics Incorporated): the stronger current systematic profile, led by momentum and value.

JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, fundamentals, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

DGX

DGX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

DGX

DGX on combined revenue and EPS growth.

Value

DGX

DGX on the peer-relative Value factor, by 8 points.

Momentum

DGX

DGX on the Momentum factor, by 22 points.

Lower downside

JPM

JPM on Risk Resilience, by 9 points.

Analyst upside

JPM

JPM on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors DGX, analyst targets favor JPM. That disagreement is the most useful thing on this page.

MeasureDGXJPMNote
Implied upside to target-0.5%+10.7%JPM has more room
Target dispersion+12%+32.2%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering611Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

Dividend growth

DGX vs JPM: regular dividend growth
Dividend metricDGXJPM
5Y dividend CAGR7.35%9.04%
2020 regular DPS$2.210$3.600
2025 regular DPS$3.150$5.550
Years increased45
No cut in windowNo (1)Yes
Cohort ranknot ranked#120

JPM grew its split-adjusted regular dividend faster over 2020–2025 — 9.04% a year against DGX's 7.35%. JPM never reduced its regular dividend in the window; DGX did in 1 year.

Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.

Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor DGX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreDGX60 vs 53
FundamentalsJPMon balancerevenue growth 1.8% vs -7.6%; EPS growth -2.1% vs -27.6%; TTM ROE 15.2% vs 17.9%; gross margin 33.1% vs 63.2%; operating margin 14.6% vs 28.2% — JPM takes 3 of 5 decided legs, not all of them
ValuationDGXValue 52 vs 44
TechnicalsDGXPrice vs 50-day 5.8% vs -2%; vs 200-day 16.2% vs 5.2%
Risk ResilienceJPMRisk Resilience 60 vs 69
Analyst expectationsJPMTarget upside -0.5% vs 10.7%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of DGX and JPM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 7 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DGX.

How the comparison changed

120 daily snapshots · Jun 29 – Oct 28

DGX lead: Strengthening — the AIQ differential moved from 1 to 7 points over 30 sessions.

Jun 29DGX leads above the line · JPM leads belowOct 28
Today
DGX +7
60 vs 53
7 sessions ago
DGX +8
58 vs 50
30 sessions ago
DGX +1
45 vs 44
90 sessions ago
DGX +6
58 vs 52

The lead changed hands 4 times in this window, most recently on Sep 14 when DGX moved ahead of JPM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

DGXConflicted

5 bullish / 1 bearish, conflicted

Only DGX

  • RSI Overbought — bearish, momentum, short horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • 52-Week High Proximity — bullish, risk, long horizon (0.0%)
  • Uptrend Structure Active — bullish, trend, long horizon
JPMConflicted

2 bullish / 1 bearish, conflicted

Only JPM

  • BB Upper Band Breach — bearish, volatility, short horizon

Both carry 2 more signals that do not separate them: Golden Cross Active, MACD Bullish Crossover.

DGX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

DGXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.43%, AIQ 0 points).

JPMDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.9%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1JPM closes the Momentum gap — currently 22 points behind, the largest single contributor to DGX's edge.
  2. 2JPM's BB Upper Band Breach resolves — a bearish volatility rule currently active against it.
  3. 3DGX's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

JPM leads on balance
MetricDGXJPM
Revenue growth (YoY)1.8%-7.6%
EPS growth (YoY)-2.1%-27.6%
Gross margin33.1%63.2%
Operating margin14.6%28.2%
Return on equity (TTM)15.2%17.9%
Debt to equity0.823.32

Performance

DGX leads 6 of 6 windows
MetricDGXJPM
1 week (5 sessions)2.8%1.2%
1 month (20 sessions)5.4%2.6%
3 months (63 sessions)4.8%-3.3%
6 months (126 sessions)28.4%9.7%
Year to date41.5%5.3%
1 year (252 sessions)34.8%12.9%

Technicals

DGX has the stronger structure
MetricDGXJPM
RSI (14)73.760.9
ADX (14)1815
Price vs 50-day5.8%-2%
Price vs 200-day16.2%5.2%
Volatility (1M, annualized)18.3%13%

Risk

JPM is the more resilient
MetricDGXJPM
Beta-0.110.73
Sharpe ratio1.30.41
Sortino ratio2.570.56
Max drawdown-11.9%-15.5%
Current drawdown-0.7%-7.1%
Annualized volatility23.9%22%
Value at risk (95%)-1.9%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, DGX or JPM?

On the Algovestiq AIQ Score, DGX is the stronger of the two as of Oct 31, 2026, scoring 60 against JPM's 53. The edge comes from momentum and value. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is DGX or JPM the better buy right now?

DGX carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor DGX over JPM?

The composite weights Quality, Value, Momentum and Risk Resilience. DGX leads Momentum by 22 points; JPM leads Risk Resilience by 9 points; DGX leads Value by 8 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, DGX or JPM?

Analyst price targets imply -0.5% upside for DGX and +10.7% for JPM, so the Street currently favors JPM. That points the opposite way to the AIQ Score, which favors DGX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, DGX or JPM?

DGX is the better-valued of the two on the peer-relative Value factor. DGX on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, DGX or JPM?

DGX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, DGX or JPM?

DGX on the Momentum factor, by 22 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, DGX or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 9 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is DGX more profitable than JPM?

JPM leads on the comparable margin measures — gross margin 33.1% vs 63.2%; operating margin 14.6% vs 28.2%; ttm roe 15.2% vs 17.9%.

Is DGX's lead over JPM getting stronger or weaker?

DGX lead: Strengthening — the AIQ differential moved from 1 to 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands 4 times in that window, most recently on 2026-09-14, when DGX moved ahead of JPM.

What would change the DGX vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Momentum gap — currently 22 points behind, the largest single contributor to DGX's edge; JPM's BB Upper Band Breach resolves — a bearish volatility rule currently active against it; DGX's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about DGX and JPM?

DGX: 5 bullish / 1 bearish, conflicted. JPM: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on DGX is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare DGX and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.